{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:05:13Z","timestamp":1793261113851,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA190152"],"award-info":[{"award-number":["U54CA190152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43TW009340"],"award-info":[{"award-number":["D43TW009340"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43CA260641"],"award-info":[{"award-number":["D43CA260641"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1CA121947"],"award-info":[{"award-number":["UM1CA121947"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01TW011470"],"award-info":[{"award-number":["K01TW011470"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002489"],"award-info":[{"award-number":["UL1TR002489"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate causes of fever, including resistance patterns, in patients undergoing cancer treatment in Malawi.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this prospective cohort study, enrolled patients undergoing chemotherapy at Kamuzu Central Hospital in Lilongwe, Malawi were given a thermometer. If a temperature of \u226538\u00b0C was recorded, they were instructed to return for hospitalization, standardized fever workup, and antibiotics. All patients were followed through 90\u2005days post-fever event or completion of chemotherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred and five patients were screened and 50 were enrolled. Of the enrollees, 26 (52%) were men and 26 (52%) were HIV positive, with a mean ART duration of 7\u2005years and CD4 count of 293\u2005cells\/\u00b5L. The most common diagnoses were aggressive non-Hodgkin lymphoma (40%) and Hodgkin lymphoma (22%). Twenty-three febrile events were recorded from 15 patients. Of the 23 events, a causative agent was isolated in 13 cases: Escherichia coli (6), Plasmodium falciparum (3), Streptococcus pneumoniae (2), Pseudomonas aeruginosa (1) and Citrobacter freundii (1). Of the six E. coli isolates, all were found to be resistant to fluoroquinolones and 4\/6 (66%) were resistant to cephalosporins. All patients but one survived; the death was attributed to Pseudomonas bacteraemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study describes laboratory-confirmed causes of neutropenic fever (NF) in cancer patients in Malawi. Gram-negative rods, followed by malaria, were the most common source of infection. Gram-negative rods were associated with high rates of antimicrobial resistance. Malaria and resistant bacterial infections should be considered for NF treatment and prevention in sub-Saharan Africa.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlae173","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T20:18:19Z","timestamp":1730233099000},"source":"Crossref","is-referenced-by-count":2,"title":["Aetiology, susceptibility and outcomes of fever in patients receiving chemotherapy in Malawi: a prospective study"],"prefix":"10.1093","volume":"6","author":[{"given":"Kaushik","family":"Puranam","sequence":"first","affiliation":[{"name":"Department of Medicine, Duke University , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1845-6577","authenticated-orcid":false,"given":"Meagan","family":"Harrington","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwards","family":"Kasonkanji","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Tegha","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Chikasema","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena L","family":"Chawinga","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maganizo B","family":"Chagomerana","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]},{"name":"Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krysiak","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]},{"name":"Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Gopal","sequence":"additional","affiliation":[{"name":"Center for Global Health, National Cancer Institute , Rockville, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4784-3227","authenticated-orcid":false,"given":"David","family":"van Duin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S","family":"Painschab","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-Malawi , Cancer Program, Lilongwe ,","place":["Malawi"]},{"name":"Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"2024102920181228600_dlae173-B1","author":"WHO, International Agency for Research on Cancer (IARC)"},{"key":"2024102920181228600_dlae173-B2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(22)00270-4","article-title":"Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs","volume":"23","author":"Bray","year":"2022","journal-title":"Lancet Oncol"},{"key":"2024102920181228600_dlae173-B3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ijc.28063","article-title":"Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991\u20132010","volume":"133","author":"Chokunonga","year":"2013","journal-title":"Int J Cancer"},{"key":"2024102920181228600_dlae173-B4","doi-asserted-by":"publisher","first-page":"e0150445","DOI":"10.1371\/journal.pone.0150445","article-title":"CHOP chemotherapy for aggressive non-Hodgkin lymphoma with and without HIV in the antiretroviral therapy era in Malawi","volume":"11","author":"Gopal","year":"2016","journal-title":"PLoS One"},{"key":"2024102920181228600_dlae173-B5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/ijc.24838","article-title":"Changing cancer incidence in Kampala, Uganda, 1991\u20132006","volume":"126","author":"Parkin","year":"2010","journal-title":"Int J Cancer"},{"key":"2024102920181228600_dlae173-B6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-319-04220-6_2","volume-title":"Cancer treatment and research, Volume 161: Infectious Complications in Cancer Patients","author":"Zembower","year":"2014"},{"key":"2024102920181228600_dlae173-B7","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1017\/ash.2022.28","article-title":"Knowledge and perceptions of antimicrobial resistance and antimicrobial stewardship among staff at a national cancer referral center in Uganda","volume":"2","author":"Gulleen","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2024102920181228600_dlae173-B8","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"key":"2024102920181228600_dlae173-B9","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"issue":"Suppl 1","key":"2024102920181228600_dlae173-B10","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2024102920181228600_dlae173-B11","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"2024102920181228600_dlae173-B12","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024102920181228600_dlae173-B13","doi-asserted-by":"publisher","first-page":"e68024","DOI":"10.1371\/journal.pone.0068024","article-title":"MRSA in Africa: filling the global map of antimicrobial resistance","volume":"8","author":"Falagas","year":"2013","journal-title":"PLoS One"},{"key":"2024102920181228600_dlae173-B14","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/jac\/dku176","article-title":"Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review","volume":"69","author":"Leopold","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2024102920181228600_dlae173-B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/cid\/ciy834","article-title":"Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998\u20132017)","volume":"69","author":"Iroh Tam","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024102920181228600_dlae173-B16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13104-019-4520-9","article-title":"Bacteremia in febrile cancer patients in Uganda","volume":"12","author":"Lubwama","year":"2019","journal-title":"BMC Res Notes"},{"key":"2024102920181228600_dlae173-B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijid.2018.09.012","article-title":"Bloodstream infections in oncology patients at Red Cross War Memorial Children\u2019s Hospital, Cape Town, from 2012 to 2014","volume":"77","author":"Mvalo","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2024102920181228600_dlae173-B18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s13104-015-1701-z","article-title":"Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting","volume":"8","author":"Obeng-Nkrumah","year":"2015","journal-title":"BMC Res Notes"},{"key":"2024102920181228600_dlae173-B19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/mpo.1246","article-title":"Bacteraemia in a paediatric oncology unit in South Africa","volume":"37","author":"van de Wetering","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"2024102920181228600_dlae173-B20","doi-asserted-by":"publisher","first-page":"ofad508","DOI":"10.1093\/ofid\/ofad508","article-title":"Etiology of fever and associated outcomes among adults receiving chemotherapy for the treatment of solid tumors in Uganda","volume":"10","author":"Gulleen","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024102920181228600_dlae173-B21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2024102920181228600_dlae173-B22","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2024102920181228600_dlae173-B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1590\/S0120-41572013000100009","article-title":"Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia","volume":"33","author":"Cort\u00e9s","year":"2013","journal-title":"Biomedica"},{"key":"2024102920181228600_dlae173-B24","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s12032-011-9858-3","article-title":"Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India","volume":"29","author":"Ghosh","year":"2012","journal-title":"Med Oncol"},{"key":"2024102920181228600_dlae173-B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/0019-509X.73574","article-title":"The effect of age on the bacteria isolated and the antibiotic-sensitivity pattern in infections among cancer patients","volume":"47","author":"Kumar","year":"2010","journal-title":"Indian J Cancer"},{"key":"2024102920181228600_dlae173-B26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12288-010-0029-z","article-title":"Microbial etiology of febrile neutropenia","volume":"26","author":"Swati","year":"2010","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2024102920181228600_dlae173-B27","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/jac\/dkad166","article-title":"Advances in antibacterial treatment of adults with high-risk febrile neutropenia","volume":"78","author":"Contejean","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2024102920181228600_dlae173-B28","author":"WHO"},{"key":"2024102920181228600_dlae173-B29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000118663","article-title":"Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies: a report of three patients","volume":"54","author":"Rapoport","year":"2008","journal-title":"Chemotherapy"},{"key":"2024102920181228600_dlae173-B30","author":"ResistanceMap"},{"key":"2024102920181228600_dlae173-B31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","article-title":"Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours","volume":"69","author":"Marin","year":"2014","journal-title":"J Infect"},{"key":"2024102920181228600_dlae173-B32","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkt002","article-title":"Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance","volume":"68","author":"Schelenz","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2024102920181228600_dlae173-B33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/21505594.2016.1141161","article-title":"Bloodstream infections in patients with solid tumors","volume":"7","author":"Gudiol","year":"2016","journal-title":"Virulence"},{"key":"2024102920181228600_dlae173-B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.7196\/SAMJ.2017.v107i7.12309","article-title":"Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy","volume":"107","author":"Ngidi","year":"2017","journal-title":"S Afr Med J"},{"key":"2024102920181228600_dlae173-B35","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.jiac.2021.06.012","article-title":"Incidence and spectrum of infections among HIV\/AIDS patients with lymphoma during chemotherapy","volume":"27","author":"Wang","year":"2021","journal-title":"J Infect Chemother"},{"key":"2024102920181228600_dlae173-B36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s40121-021-00445-3","article-title":"Clinical characteristics and outcome of bloodstream infections in HIV-infected patients with cancer and febrile neutropenia: a case\u2013control study","volume":"10","author":"Puerta-Alcalde","year":"2021","journal-title":"Infect Dis Ther"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/6\/5\/dlae173\/60198131\/dlae173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/6\/5\/dlae173\/60198131\/dlae173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T20:18:21Z","timestamp":1730233101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlae173\/7848855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlae173","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,3]]},"article-number":"dlae173"}}